FDA NDC Directory · JSON-LD · Markdown

Rivastigmine

NDC 70771-1950 · HUMAN PRESCRIPTION DRUG · PATCH, EXTENDED RELEASE

Labeler / ManufacturerZydus Lifesciences Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA206318
Dosage form / routePATCH, EXTENDED RELEASE · TRANSDERMAL
Active ingredientsRIVASTIGMINE (9.5 mg/24h)
Marketing started20190306
Package count1

External sources

Source: openFDA. Public-domain (CC0).